About ATERONON™
Discovery
When science and nature combine
It has long been recognised that populations eating a tomato-rich ‘Mediterranean’ diet, benefit by having a lower incidence of heart or circulatory-related diseases. Hundreds of scientific studies into the Mediterranean diet have helped to reveal the tomato-derived anti-oxidant, lycopene, as a key ingredient contributing to these improved levels of health.
Lycopene is known to be a powerful antioxidant, which if absorbed in the right way, can help to prevent the oxidation of fats in the blood, which can otherwise lead to the build-up of plaque in our arteries.
Using a dietary supplement that can implement the inhibition of oxidative stress is one of the goals that we all, as surgeons and cardiologists, must follow in order to prolong survival.
Michele Gulizia (President, Italian Association of Arrhythmias and Cardiac Pacing, AIAC)
In its raw form, lycopene is composed of rather large crystals that are difficult for the body to absorb and therefore use. Research projects around the world have been studying this problem for many years and looking for ways to solve it.
After nearly a decade of work, scientists at Cambridge Theranostics (a spin-out biotechnology company from Cambridge University, part funded by The British Heart Foundation), working with research started by food company Nestle, have identified a way to solve this problem. The result of this work is Ateronon - a unique and patented formulation of natural ingredients that has overcome the problem of helping the body to absorb lycopene successfully.
ATERONON™’s unique and patented formulation manages to break down the larger lycopene crystals so that they are more easily absorbed by the body and so that the body can benefit from the health properties of this powerful and natural antioxidant.
In order to confirm this discovery, ATERONON™ has undergone several clinical trials to measure its ability to deliver bioavailable levels of lycopene and the subsequent impact on the oxidation of LDL cholesterol. The results of the trials show that effective levels of lycopene in the bloodstream are reached after as little as 2 weeks of daily use.
The result of this increased absorption, is that after 2 months of daily use, ATERONON™ typically inhibits LDL cholesterol oxidation by more than 90% - a breakthrough in offering support to help keep our hearts and arteries healthy.